Hormones

Hormones


Negotiable Min Order Quantity Unit

Required Quantity
Place of Origin
Payment Terms
Negotiable
Production method
Negotiable
Shipping / Lead Time
Negotiable / Negotiable
Keyword
Category
Amino Acids and Coenzymes

Myungmoon Pharm. Co., Ltd.

Country / Year Established
South Korea South Korea /
Business type
Others
Verified Certificate

16

TRADE TOWER

DUNS

Product name Hormones Certification -
Category Amino Acids and Coenzymes Ingredients -
Keyword - Unit Size -
Brand name - Unit Weigh -
origin Stock -
Supply type - HS code -

Product Information

Esdiol half Tab.(Estradiol hemihydrate 1.03mg, Norethisterone acetaet 0.5mg)

Composition : One tablet contains
Estradiol hemihydrate - 1.03mg
Norethisterone acetate - 0.5mg

Indication & Usage :

  • Treatment of moderate to severe vasomotor symptoms associated with the menopause
  • Treatment of vulvar and vaginal atrophy
  • Prevention of postmenopausal osteoporosis
  • Refer to insert-paper for further information

Dosage & Administration :

  • Esdiol-Half therapy consists of a single tablet to be taken once daily.
  • Refer to insert-paper for further information

Package : 28 Tablets

 
Esgen Tab.(Estropipate 0.75mg, 1.5mg)

Composition : One tablet contains
Estropipate - 0.75mg(Sodium estrone sulfate 0.625mg)
Estropipate - 1.5mg(Sodium estrone sulfate 1.25mg)

Indication & Usage, Dosage & Administration

  • Treatment of moderate to severe vasomotor symptoms associated with the menopause.
  • Treatment of vulval and vaginal atrophy
  • Treatment of hypoestrogenism due to hypogonadism, castration or primary ovarian failure
  • Prevention of osteoporosis

Package : 0.625mg/Tab x 500, 300Tab(PTP), 1.25mg/Tab x 500

 
Esgen Vaginal Cream(Estropipate 1.5mg/g)

Composition : 1g contains
Estropipate - 1.5mg

Indication & Usage : Atrophic vaginitis and vulvar atrophy

Dosage & Administration :
Intravaginal, 2 to 4mg of estropipate daily

Package : 15g/Tube, 42.5g/Tube

 
Libron Tab.(Tibolone 2.5mg)

Composition : One tablet contains
Tibolone - 2.5mg

Indication & Usage :

  • Symptomatic treatment of hot flushes and associated sweating resulting from the natural or surgical menopause.
  • Prevention of postmenopausal osteoporosis.

Dosage & Administration

  • The dosage is one tablet per day.
  • Refer to insert-paper for further information

Package : 300 Tablets

 
Progen Tab.(Medroxyprogesterone acetate 2.5mg/5mg/10mg)

Composition : One tablet contains
Medroxyprogesterone acetate - 2.5mg
Medroxyprogesterone acetate - 5mg
Medroxyprogesterone acetate - 10mg

Indication & Usage :

  • Secondary amenorrhea
  • Abnormal uterine bleeding due to hormonal imbalance in the absence of organic pathology, such as fibroids or uterine cancer.
  • Endometriosis of indisposition or moderate.
  • Concomitant medication with estrogen associated with menopause women who is not practice the hysterectomy.

Package
- 2.5mg/Tab x 300, 300Tab(P.T.P)
- 5mg/Tab x 300,
- 10mg/Tab x 300

B2B Trade

Price (FOB) Negotiable transportation -
MOQ Negotiable Leadtime Negotiable
Payment Options Negotiable Shipping time Negotiable

Myungmoon Pharm. Co., Ltd.

Country / Year Established
South Korea South Korea /
Business type
Others

16

TRADE TOWER

DUNS

President
LEE, GYU HUOK
Address
Myungmoon B/D, 946-18, Dokok-Dong, Gangnam-Ku, Korea
Product Category
Beauty & Personal Care,Chemical & Pharmaceutical Machinery,Pharmaceuticals
No. of Total Employees
101-500
Company introduction

In 1983, Myungmoon Pharm. Co., Ltd. was established for the improvement of national health. It is achieving remarkable development via research and development, production, and sales based on its founding principle: Advancement, Harmony, and Creation. Myungmoon Pharm. Co., Ltd. is an acknowledged manufacturer to produce the finished medicines; Injection, Tablet, Capsule, Patches, Solution and Creams.

Nowadays, Myungmoon Pharm. Co., Ltd. produces more than 250 specialized and general medicines and has more than 400 specialized and generalmedicine licenses to be able to manufacture. Myungmoon Pharm. Co., Ltd. is focusing on our research and development efforts so that Myungmoon Pharm. Co., Ltd. is launching more than 20 new products every year.

Myungmoon Pharm. Co., Ltd. established the new plant for API in 2008. Myungmoon Pharm. Co., Ltd has Gabapentin(USP) and the other 8 API products now, however, Myungmoon Pharm. Co., Ltd. would have many new API products in the foreseeable future. To gain a foothold on biomedicine products, outsourcing strategies are preceding the use of trusted clinical agency CRO and production agency CMO, and Myungmoon Pharm. Co., Ltd has already started to develop human growth hormones through a bio-venture corporation. Within 2 or 3 years, Myungmoon Pharm. Co., Ltd. should be launching bio-similar, including EPO and the processing of the complement of plants for biomedical products as well as the development of advanced medical bioethics, including monoclonal antibodies.

Myungmoon Pharm. Co., Ltd. is sharply developing to be a professional and global treatment company in the world.

Main Markets

China China

Main Product

Related Products

Other buyers also search

Membership Grade

BUYER

Biz Pro VIP

SELLER

Biz Pro VIP
팝업닫기
Live Chat A new message arrives
from a business partner.

No Data

  • There is no data to load
  • Check out the My TK > My Inquiries list.
  • After agreeing to the use of the Live Chat service, the list is printed only when there is at least one history of receiving or sending a Live Chat request.

If you have not yet agreed to use the Live Chat service,

You can use the Live Chat freely after agreeing to the use of the Live Chat service.

View more
View more